Researchers evaluated links between lifestyle and dietary index scores and risk of death in a prospective, multiethnic cohort of men diagnosed with non-metastatic prostate cancer.

Pathos AI, ( a clinical-stage biotechnology company focused on re-engineering drug development through artificial intelligence, announced the first patient has been dosed in the Company’s Phase 1b/2a ...

The test can be used to better stratify cancer patients and determine the likelihood of breast cancer metastasizing.

"It is with profound sadness that we announce the passing of Eddie Jordan OBE, the ex-Formula 1 team owner, TV pundit and ...

In the ongoing quest to combat cancer, one of the most promising and accessible tools may be right at our fingertips: ...

The IDEA team will help guide Candel’s commercial strategy development and support the Company’s commercial projects related to CAN-2409. Through this partnership, Candel will gain access to a ...

An expert discusses other ongoing investigations exploring radium-223-based combinations for the treatment of metastatic castration-resistant prostate cancer, highlighting key studies and their ...

Merus (NASDAQ:MRUS – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at Guggenheim in a report issued on Tuesday,Benzinga reports. They presently have a $109.00 target price ...

ProCure Proton Therapy Center marks its 13th anniversary this March, celebrating a legacy of state-of-the-art technology with a patient-centered approach in cancer care. Since 2012, ProCure has helped ...

Monte Rosa Therapeutics’ plan to develop a molecular glue degrader in a wide range of cancers has come unstuck. | Monte Rosa ...

Professors Rik Bryan and Nicholas James explain how an image-directed pathway for muscle-invasive bladder cancer improves ...